Walgreens used this strategy to reduce theft. Turns out, it was bad for business
Over the years the pharmacy chain used strategy to combat shoplifting. Walgreens CEO Tim Wentworth said the company’s decision to lock up products after reporting a 52% increase in stolen inventory has backfired, according to multiple reports.
Walgreens Admits What Many Already Suspected About Anti-Theft Measures
In an earnings call, executive Tim Wentworth conceded that locking products up might not be the best move for boosting sales.
Walgreens CEO reveals anti-theft measures of locking up products had the opposite effect
CEO Tim Wentworth admitted in a recent fiscal report call that combatting shoplifting by locking up items has led to customer dissatisfaction.
Walgreens CEO says locking up merchandise harmed sales
"When you lock things up … you don't sell as many of them. We've kind of proven that pretty conclusively," Wentworth said. "I don't have anything magnificent to share with you today. It is a hand-to-hand combat battle still,
Walgreens says locking up products to prevent shoplifting hurts sales
Keeping products under lock and key dissuaded customers from purchasing them, Walgreens said in earnings call.
Anti-shoplifting effort is hurting sales, Walgreens says
Tim Wentworth, CEO of Walgreens Boots Alliance, the parent company of Duane Reade, acknowledged to investors during a Jan. 10 earnings call that the company's asset protection tactic of locking merchandise to prevent retail theft has slowed sales.
Walgreens CEO admits anti-theft measures ‘largely ineffective’: ‘When you lock things up, you don’t sell as many of them’
The top executive at Walgreens lamented the loss of sales from putting items like toothpaste behind lock and key to crack down on rampant shoplifting that has plagued pharmacy chains around the country.
Walgreens CEO describes drawback of anti-shoplifting strategy: ‘When you lock things up…you don’t sell as many of them’
Walgreens' CEO talked about the flip side of investing in increased security on a recent earnings call.
Walgreens Says Locking Up Products Has Hurt Sales
The CEO of Walgreens admits that locking up products to deter theft is irritating paying customers and is hurting sales. The company has found that people will leave without buying products instead of waiting for an employee to unlock access to something as simple as a tube of toothpaste.
Newser on MSN5h
Walgreens: We Accidentally Proved Locks Are a Dumb Idea
Consider it a simple economic truth, one that ordinary Americans evidently knew long before CEOs: "When you lock things up ..
Walgreens CEO: Stopping shoplifting is a "hand-to-hand combat battle"
Walgreens is struggling to deter shoplifting at its stores, according to CEO Tim Wentworth, who described it as "a ...
Modern Healthcare6d
Walgreens targets PBM contracts, moves ahead with VillageMD sale
Walgreens' sale of its majority stake in primary and multispecialty care provider VillageMD is underway, CEO Tim Wentworth ...
HealthLeaders Media2d
Walgreens' Turnaround Takes Shape in Midst of Significant Q1 Losses
Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...
Parade on MSN22h
Walgreens Admits Controversial Policy Backfired and Shoppers Aren't at All Surprised
In a recent call with analysts, Walgreens CEO Tim Wentworth said preventing theft in stores "is a hand-to-hand combat battle ...
Walgreens Pharmacy Strength And CEO Comments Toss Cold Water On Private Equity Deal
Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...
Crain's Chicago Business5d
CEO envisions a smaller, stronger Walgreens as store closures kick in
Deerfield-based Walgreens closed 70 stores in its first quarter, and the company intends to speed up the pace moving forward, ...
kffhealthnews3d
Walgreens Making Progress Despite Shrinking Prescription Reimbursement
According to CEO Tim Wentworth, the company has been modifying contracts with insurers who pay for prescriptions and adjusting for high-cost drugs. Meanwhile, the VillageMD sale is moving along.